Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 2 Drug Alert (Action within 48 hours): Greystone Ltd - Amlodipine 5mg and 10mg Tablets - EL (09)A/16

Document details:

Type: Drug Alert
Series No: EL (09)A/16
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 2
Price: free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

DRUG ALERT

Class 2 medicines recall
Action within 48 hours
Pharmacy and wholesaler level recall
29 June 2009 EL (09)A/16 Our ref:  MDR 56-06/09

Dear Healthcare Professional,

Greystone Ltd

Amlodipine 5mg and 10mg Tablets

Amlodipine besilate

PL 19702/0003 and PL 19702/0004

5mg Tablets

Batch Number

Expiry Date

Pack Size

First Distributed

T7A010707

06/2010

28

28/08/2007

T7A020707

06/2010

28

29/08/2007

T7A030707

06/2010

28

29/08/2007

T7A010208

01/2011

28

08/04/2008

T7A020208

01/2011

28

08/04/2008

T7A030208

01/2011

28

08/04/2008

 

10mg Tablets

Batch Number

Expiry Date

Pack Size

First Distributed

T8A010707

06/2010

28

03/09/2007

T8A020707

06/2010

28

03/09/2007

T8A030707

06/2010

28

03/09/2007

T8A010208

01/2011

28

08/04/2008



Greystone Ltd are recalling the above products due to serious GMP deficiencies found during an inspection of their contract manufacturer.

All unused stock of the above batches should be quarantined and returned for credit.

For any Medical Information enquiries related to this case please call Greystone Ltd on 07941 197095 or 020 8904 9059.

For enquiries related to stock returns and credit please call Greystone Ltd on 07941 197095 or 020 8904 9059.

Recipients of this Drug Alert should bring this to the attention of relevant contacts by copy of this letter. Primary Care Trusts are requested to forward this to relevant clinics, General Practitioners and Community Pharmacists.

Yours faithfully

Ian Holloway
MHRA DMRC Manager

MHRA Distribution (further recipients by cascade):
Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)
Page last modified: 30 June 2009